comparemela.com

Latest Breaking News On - Helen genova - Page 3 : comparemela.com

Telehealth services were highly utilized by individuals with multiple sclerosis during COVID-19

While many people skipped regular health check-ups during the COVID-19 pandemic, new research indicates that people with multiple sclerosis (MS) used online telehealth services more frequently to keep in contact with their health care providers and were highly satisfied with the outcome.

New study to examine the effects of MS disease-modifying therapy on cognitive fatigue

New study to examine the effects of MS disease-modifying therapy on cognitive fatigue Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS). John DeLuca, PhD, senior vice president of Research and Training, is principal investigator for the study titled, A Biomarker for Cognitive Fatigue in MS using Functional Imaging . The study team includes Glenn Wylie, DPhil, director of the Rocco Ortenzio Neuroimaging Center at Kessler Foundation, Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research, and Helen Genova, PhD, assistant director of the Center for Neuropsychology and Neuroscience Research.

Kessler Foundation to study effects of MS disease-modifying therapy on cognitive fatigue

 E-Mail IMAGE: Dr. DeLuca is senior vice president of Research and Training at Kessler Foundation and professor of neurology and physical medicine and rehabilitation at Rutgers New Jersey Medical School. He. view more  Credit: Kessler Foundation East Hanover, NJ. February 8, 2021 - Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS). John DeLuca, PhD, senior vice president of Research and Training, is principal investigator for the study titled, A Biomarker for Cognitive Fatigue in MS using Functional Imaging . The study team includes Glenn Wylie, DPhil, director of the Rocco Ortenzio Neuroimaging Center at Kessler Foundation, Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research, and Helen Genova, PhD, assistant d

Study sheds light on deficits in processing speed in individuals with spinal cord injury

Study sheds light on deficits in processing speed in individuals with spinal cord injury ANI | Updated: Jan 03, 2021 14:13 IST New Jersey [US], January 3 (ANI): On studying processing speed deficits in individuals with spinal cord injury (SCI), a team of rehabilitation researchers found that the SCI group and older controls had similar activation patterns, but the SCI group differed significantly from their age-matched controls. The scientists have compared SCI patients and their brain activation patterns with those of healthy age-matched controls, and older healthy individuals. The article, The neural mechanisms underlying processing speed deficits in individuals who have sustained a spinal cord injury: A pilot study was published by Brain Topography. The authors are scientists with expertise in research in cognitive rehabilitation and SCI rehabilitation: Glenn Wylie, DPhil, Nancy D. Chiaravalloti, PhD, Erica Weber, PhD, Helen Genova, PhD

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.